Inj moxifloxacin (fres kabi)
Products billed under this code include Moxifloxacin HCl.
Payment limit per 100 MG, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J2281
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Moxifloxacin HCl | FreseniUS Kabi USA, LLC | 63323-0850-74 | 48 | $318.768 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $6.641 | $0.00 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted September 17, 2026 |
| 3Q26 | $6.641 | $0.00 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted September 15, 2026 |
| 2Q26 | $6.641 | $0.00 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted September 15, 2026 |
| 1Q26 | $6.641 | −$0.771 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted September 15, 2026 |
| 4Q25 | $7.412 | −$0.349 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted September 8, 2026 |
| 3Q25 | $7.761 | +$0.658 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted March 10, 2026 |
| 2Q25 | $7.103 | +$0.937 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted March 10, 2026 |
| 1Q25 | $6.166 | −$1.051 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted December 19, 2025 |
| 4Q24 | $7.217 | −$0.346 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted June 11, 2025 |
| 3Q24 | $7.563 | +$0.078 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted June 11, 2025 |
| 2Q24 | $7.485 | +$1.679 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted March 11, 2025 |
| 1Q24 | $5.806 | +$0.491 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted December 19, 2024 |
| 4Q23 | $5.315 | +$0.82 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted October 10, 2024 |
| 3Q23 | $4.495 | −$4.274 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted June 5, 2024 |
| 2Q23 | $8.769 | −$0.959 | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted February 23, 2024 |
| 1Q23 | $9.728 | – | 100 MG | Inj moxifloxacin (fres kabi) | v1, posted December 6, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023